by Konstantina Zafeiropoulou
Following the GMFH 2022 Year at a Glance report, it is time for a flashback in the latest research on cancer microbiome. This post ranges between the epidemiology, etiology and diagnosis of cancer, looking at the role of fungal and bacterial gut microbiome in all three health care branches.
Scientists have started to take an interest in the physiological relevance of fungal microbiota. Here, Harry Sokol and Mathias L. Richard clarify the relevance of the mycobiota and how its study might impact on clinical practice in the foreseeable future.
by Andreu Prados
Until now, scientists have focused on the milk’s bacterial fraction without exploring the contribution of other microorganisms such as colonizing fungi. New data support the potential role of breast milk in the initial seeding of fungal species when colonizing the infant gut.
by Andreu Prados
A recent study has found that mycobiome differences exist at each infant body site over the first month of life and mode of birth influences key fungal groups.
by Andreu Prados
A new study has found that high-fat diets can alter how bacteria and fungi communicate in mouse intestines, contributing to obesity.
by Andreu Prados
A recent review article explores the role of the interactions between bacteria and fungi in Crohn’s disease and potential strategies to target the gut microbiota in gastrointestinal diseases.
by Andreu Prados
A recent study, led by Prof. Mahmoud A. Ghannoum from the Centre for Medical Mycology at the Case Western Reserve University in Cleveland, Ohio, USA, has identified new specific interkingdom bacteria and fungi interactions that may be key players in Crohn’s disease.
